Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) where bromo and trifluoromethyl groups aid in enhancing metabolic stability and binding affinity. Its hydroxyl functionality allows for further chemical modifications, making it valuable in constructing complex organic molecules. Commonly employed in cross-coupling reactions and as a building block in agrochemicals and specialty materials. Its structural features also make it suitable for research in medicinal chemistry for designing novel bioactive compounds.